Collegeville, PA, United States of America

Kevin J Duffy

This inventor holds 32 USPTO granted patents and 10 published patent applications, plus 1 CIPO patent and 4 EPO patents, primarily in Cancer Therapeutics. Top assignees: Smithkline Beecham Corporation, Cytokinetics, Inc., Glaxosmithkline LLC. Active years: 2002-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kevin J Duffy. Retrieved from https://idiyas.com/inventor/kevin-j-duffy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 32 (Patent Applications = 10)

% Patents Active = 40.6

CIPO Patents = 1

EPO Patents = 4 (Patent Applications = 7)

Average Co-Inventor Count = 4.3

ph-index = 8

Forward Citations = 198(Granted Patents)

Location History:

Norristown, PA (US) (2002 - 2005)
Philadelphia, PA (US) (2009 - 2014)
Collegeville, PA (US) (2005 - 2023)

Company Filing History:

18 out of 2,198

Smithkline Beecham Corporation

Ideaya Biosciences, Inc.

Glaxosmithkline Intellectual Property (No.2) Limited

patents

7. 1 out of 1

Glaxosmithkline Intellectual Property (No.4) Limited

patent

8. 1 out of 242

Glaxosmithkline Intellectual Property Development Limited

patents

9. 1 out of 139

Ligand Pharmaceuticals, Inc.

patents

10. 1 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 2002-2026

Loading Chart...

Areas of Expertise:

Prolyl Hydroxylase Inhibitors

Thrombopoietin Mimetics

Anti-Cancer Agents

Imidazole-Benzamide

N-Substituted Glycine Derivatives

Imidazopyridinyl Benzamide

Mitotic Kinesin Inhibitors

G-CSF Mimetics

Naphthimidazole Derivatives

Semicarbazone Derivatives

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12766150 - Substituted thiadiazolyl derivatives as DNA polymerase theta inhibitors (2026-10-20),

2. 12398131 - Thiadiazolyl derivatives as DNA polymerase theta inhibitors and uses thereof (2025-08-26),

3. 11643397 - Prolyl hydroxylase inhibitors (2023-05-09),

4. 9718848 - Compounds (2017-08-01),

5. 8772507 - Imidazole-benzamide anti-cancer agents (2014-07-08),

6. RE44613 - N-substituted glycine derivatives: hydroxylase inhibitors (2013-11-25),

7. 8324208 - Prolyl hydroxylase inhibitors (2012-12-04),

8. 8207340 - Imidazopyridinyl benzamide mitotic kinesin inhibitors (2012-06-26),

9. 8163919 - Imidazopyridinyl benzamide mitotic kinesin inhibitors (2012-04-24),

10. 7795448 - Imidazoyl-benzamide anti-cancer agents (2010-09-14),

11. 7790704 - Thrombopoietin mimetics (2010-09-07),

12. 7674887 - Thrombopoietin mimetics (2010-03-09),

13. 7674792 - 5(Z)-5-(6-quinoxalinylmethylidene)-2-[2,6-dichlorophenyl)amino]-1,3-thiazol-4(5H)-one (2010-03-09),

14. 7648971 - Thrombopoietin mimetics (2010-01-19),

15. 7618981 - Imidazopyridinyl-benzamide anti-cancer agents (2009-11-17),

Title: Kevin J Duffy - Pioneering Inventor from Collegeville, PA

Introduction: Kevin J Duffy is a renowned inventor hailing from Collegeville, Pennsylvania. His innovative spirit and dedication to creating groundbreaking solutions have earned him a significant place in the world of patents and inventions.

Latest Patents: Kevin J Duffy's latest patents include cutting-edge technologies in the fields of renewable energy, sustainable agriculture, and advanced robotics. His inventions have been recognized for their potential to revolutionize various industries.

Career Highlights: With a career spanning over two decades, Kevin J Duffy has established himself as a leading figure in the innovation landscape. His contributions have led to numerous successful products and processes that have had a lasting impact on society.

Collaborations: Throughout his career, Kevin J Duffy has collaborated with top research institutions, universities, and companies to bring his inventions to life. His ability to work across disciplines and industries has resulted in truly transformative innovations.

Conclusion: Kevin J Duffy's passion for pushing the boundaries of what is possible through innovation is evident in his impressive body of work. His relentless pursuit of excellence continues to inspire the next generation of inventors and creators.

Profile summary based on public USPTO records.